Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

This article is part of the supplement: 24th Annual Meeting of the National Cancer Institute of Mexico

Open Access Meeting abstract

Apoptosis induced by cisplatin but not by 5-FU in colon cancer cells depends on Omi/Htra2 protein

Franz G Pruefer*, Floria Lizárraga-Sánchez, Vilma Maldonado-Lagunas and Jorge Meléndez-Zajgla

Author Affiliations

Subdirección de Investigación Básica, Instituto Nacional de Cancerología, México DF

For all author emails, please log on.

BMC Cancer 2007, 7(Suppl 1):A11  doi:10.1186/1471-2407-7-S1-A11


The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2407/7/S1/A11


Published:5 February 2007

© 2007 Pruefer et al; licensee BioMed Central Ltd.

Background

The most frequent cause of treatment failure in patients with advanced cancer is chemotherapy resistance. One of the mechanisms of chemotherapy resistance is failure to trigger apoptosis of cancer cells. Apoptosis can be induced by two pathways, intrinsic and extrinsic. The intrinsic pathway is activated by mitochondrial release of apoptotic proteins secondary to genomic stress. Omi/Htra2 is one of the released mitochondrial proteins. It is a serine protease which inactivates the family of Inhibitor of Apoptosis Proteins (IAPs).

Materials and methods

In this study, the participation of Omi/Htra2 in cell death induced by the chemotherapeutic agents Cisplatin and 5-Fluorouracil (5-FU) was assessed in human colon cancer cells SW480. 5-FU and Cisplatin induced apoptosis in this cell line as shown by cell morphology and further confirmed by showing cleavage of caspase 3. Both drugs induced apoptosis via the intrinsic pathway as shown by mitochondrial release of cytochorome C.

Results

5-FU and Cisplatin promoted the release of Omi/Htra2 from the mitochondria to the cytosol, as demonstrated by immunofluorescence and western blot assays of subcellular fractions. When cells were exposed to an Omi/Htra2 serine protease inhibitor, UCF-101, cell death was significantly suppressed of cells exposed to Cisplatin, but not to 5-FU. Additionally Omi/Htra2 inhibition partially prevented reproductive cell death measured by clonogenic assays of cells exposed to Cisplatin but not to those exposed to 5-FU

Conclusion

This study shows that Omi/Htra2 participates in cell death induced by CDDP but not by 5-FU in colon cancer cells. In addition, our findings suggest downstream differences in the intrinsic pathway of apoptosis triggered by diverse antineoplastic drugs.